A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

BACKGROUND: The Charlson Comorbidity Index is a poor predictor of mortality in men with castration resistant prostate cancer (CRPC). To improve this prediction, we created a comorbidity index based on filled prescriptions intended to be used in registry-based studies. MATERIALS AND METHODS: In a pop...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallara, Giuseppe, Gedeborg, Rolf, Bill-Axelson, Anna, Garmo, Hans, Stattin, Pär
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318265/
https://www.ncbi.nlm.nih.gov/pubmed/34320037
http://dx.doi.org/10.1371/journal.pone.0255239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318265/
https://www.ncbi.nlm.nih.gov/pubmed/34320037
http://dx.doi.org/10.1371/journal.pone.0255239

Ejemplares similares